This Article Full Text Full Text (PDF) All Versions of this Article: 114/20/2148    most recent CIRCULATIONAHA.106.666396v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, Y.-H. Search for Related Content PubMed PubMed Citation Articles by Kim, Y.-H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Coronary Artery Disease Hazardous Substances DB TAXOL Related Collections Chronic ischemic heart disease Catheter-based coronary interventions: stents

(Circulation. 2006;114:2148-2153.)
© 2006 American Heart Association, Inc.

Interventional Cardiology

Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease

Young-Hak Kim, MD, PhD; Seong-Wook Park, MD, PhD; Seung-Whan Lee, MD, PhD; Duk-Woo Park, MD; Sung-Cheol Yun, PhD; Cheol Whan Lee, MD, PhD; Myeong-Ki Hong, MD, PhD; Hyun-Sook Kim, MD, PhD; Jae-Ki Ko, MD, PhD; Jae-Hyeong Park, MD, PhD; Jae-Hwan Lee, MD, PhD; Si Wan Choi, MD, PhD; In-Whan Seong, MD, PhD; Yoon Haeng Cho, MD; Nae-Hee Lee, MD; June Hong Kim, MD, PhD; Kook-Jin Chun, MD, PhD; Seung-Jung Park, MD, PhD, for the Long-DES-II Study Investigators

From Asan Medical Center (Y.-H.K., S.-W.P., S.-W.L., D.-W.P., S.-C.Y., C.W.L., M.-K.H., S.-J.P.), University of Ulsan College of Medicine, Seoul, Korea; Chonbuk National University Hospital (H.-S.K., J.-K.K.), Jeonju, Korea; Chungnam National University Hospital (J.-H.P., J.-H.L., S.W.C., I.-W.S.), Daejeon, Korea; Soonchunhyang University Bucheon Hospital (Y.H.C., N.-H.L.), Soonchunhyang, Korea; and Pusan National University Hospital (J.H.K., K.-J.C.), Busan, Korea.

Correspondence to Seung-Jung Park, MD, PhD, Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea. E-mail sjpark{at}amc.seoul.kr

Received September 22, 2006; revision received October 6, 2006; accepted October 13, 2006.

Background— Outcomes remain relatively unfavorable for stent-based coronary intervention of lesions with long diseased segments. This study compared sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) for long coronary lesions.

Methods and Results— The present randomized, multicenter, prospective study compared the use of long (32 mm) SES with PES in 500 patients with long (25 mm) native coronary lesions. The primary end point of the trial was the rate of binary in-segment restenosis according to follow-up angiography at 6 months. The SES and PES groups had similar baseline characteristics. Lesion length was 33.9±11.6 mm in the SES group and 34.5±12.6 mm in the PES group (P=0.527). The in-segment binary restenosis rate was significantly lower in the SES group than in the PES group (3.3% versus 14.6%; relative risk 0.23; P<0.001). In-stent late loss of lumen diameter was 0.09±0.37 mm in the SES group and 0.45±0.55 mm in the PES group (P<0.001). In patients with restenoses, a pattern of focal restenosis was more common in the SES group than in the PES group (100% versus 53.3%, P=0.031). Consequently, SES patients had a lower rate of target-lesion revascularization at 9 months (2.4% versus 7.2%, P=0.012). The incidence of death (0.8% in SES versus 0% in PES, P=0.499) or myocardial infarction (8.8% in SES versus 10.8% in PES, P=0.452) at 9 months of follow-up was not statistically different between the 2 groups.

Conclusions— For patients with long native coronary artery disease, SES implantation was associated with a reduced incidence of angiographic restenosis and a reduced need for target-lesion revascularization compared with PES implantation.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				M. Billinger, J. Beutler, K. R. Taghetchian, A. Remondino, P. Wenaweser, S. Cook, M. Togni, C. Seiler, C. Stettler, F. R. Eberli, et al. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients Eur. Heart J., March 2, 2008; 29(6): 718 - 725. [Abstract] [Full Text] [PDF]

				A. M. Galloe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P. R. Hansen, N. Bligaard, K. Saunamaki, A. Junker, J. Aaroe, et al. Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice: The SORT OUT II Randomized Trial JAMA, January 30, 2008; 299(4): 409 - 416. [Abstract] [Full Text] [PDF]

				A. Schomig, A. Dibra, S. Windecker, J. Mehilli, J. Suarez de Lezo, C. Kaiser, S.-J. Park, J.-J. Goy, J.-H. Lee, E. Di Lorenzo, et al. A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1373 - 1380. [Abstract] [Full Text] [PDF]

				D. J. Kereiakes The Emperor's New Clothes: Another Cypher Versus Taxus Post-Hoc Meta-Analysis J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1381 - 1385. [Full Text] [PDF]

				N. M M Pires, D. Eefting, M. R de Vries, P. H A Quax, and J W. Jukema Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries Heart, August 1, 2007; 93(8): 922 - 927. [Abstract] [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., July 17, 2007; 50(3): 270 - 285. [Full Text] [PDF]